| ［1］Arai T, Hasegawa M, Akiyama H, et al. TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis［J］. Biochem Biophys Res Commun, 2006, 351(3):602-611.［2］Chiò A, Calvo A, Moglia C,et al. Amyotrophic lateral sclerosis-frontotemporal lobar dementia in 3 families with p.Ala382Thr TARDBP mutations［J］. Arch Neurol， 2010, 67(8):1002-1009.［3］Borroni B, Bonvicini C, Alberici A, et al. Mutation within TARDBP leads to frontotemporal dementia without motor neuron disease［J］. Hum Mutat, 2009, 30(11):E974-E983.［4］Mackenzie IR, Rademakers R, Neumann M. TDP-43 and FUS in amyotrophic lateral sclerosis and frontotemporal dementia［J］. Lancet Neurol, 2010, 9(10):995- 1007.［5］Benussi L, Ghidoni R, Pegoiani E, et al. Progranulin Leu- 271LeufsX10 is one of the most common FTLD and CBS associated mutations worldwide［J］. Neurobiol Dis, 2009,33(3):379-385.［6］Kelley BJ, Haidar W, Boeve BF, et al. Prominent phenotypic variability associated with mutations in progranulin［J］. Neurobiol Aging, 2009, 30(5):739-751.［7］Zhang YJ, Xu YF, Dickey CA, et al. Progranulin mediates caspasedependent cleavage of TAR DNA binding protein-43［J］. J Neurosci, 2007, 27(39):10530-10534.［8］Custer SK, Neumann M, Lu H, et al. Transgenic mice expressing mutant forms VCP/p97 recapitulate the full spectrum of IBMPFD including degeneration in muscle, brain and bone［J］. Hum Mol Genet, 2010, 19(9):1741-1755.［9］Gijselinck I, Engelborghs S, Maes G, et al. Identification of 2 loci at chromosomes 9 and 14 in a multiplex family with frontotemporal lobar degeneration and amyotrophic lateral sclerosis［J］. Arch Neurol, 2010, 67(5):606-616.［10］Kwiatkowski TJ, Bosco DA. LeClerc L, et al. Mutations in the FUS/TLS gene on chromosome 16 cause familial amyotrophic lateral sclerosis［J］. Science,2009, 323(5918):1205-1208.［11］Rademaker R, Stewart H, Dejesus-Hernandez M, et al. FUS gene mutations in Amyotrophic Lateral Sclerosis［J］. Muscle Nerve, 2010, 42(2):170-176.［12］Blair IP, Williams KL, Warraich ST, et al. FUS mutations in Amyotrophic Lateral Sclerosis: clinical, pathological, neurophysiological and genetic analysis［J］. J Neurol Neurosurg Psychiatry, 2010, 81(6):639-645.［13］Strong MJ. The evidence for altered RNA metabolism in amyotrophic lateral sclerosis (ALS)［J］. J Neurol Sci, 2010, 288(1-2):1-12.［14］Ou SHI, Wu F, Harrich D, et al. Cloning and characterization of a novel cellular protein, TDP-43, that binds to human immunodeficiency virus type 1 TAR DNA sequence motifs［J］. J Virol, 1995, 69(6):3584-3596.［15］Makeyev AV, Liebhaber SA. The poly(C)-binding proteins: a multiplicity of functions and a search for mechanisms［J］. RNA, 2002, 8(3):265-278.［16］Ayala YM, Pagani F, Baralle FE. TDP-43 depletion rescues aberrant CFTR exon 9 skipping［J］. FEBS Lett, 2006, 580(5):1339-1344.［17］Strong MJ, Volkening K, Hammond R, et al. TDP43 is a human low molecular weight neurofilament (hNFL) mRNA-binding protein［J］. Mol Cell Neurosci, 2007, 35(2):320-327.［18］Volkening K, Leystra-Lantz C, Yang W, et al. Tar DNA binding protein of 43 kDa (TDP-43), 14-3-3 proteins and copper/zinc superoxide dismutase (SOD1) interact to modulate NFL mRNA stability. Implications for altered RNA processing in amyotrophic lateral sclerosis (ALS)［J］. Brain Res, 2009, 1305(11):168-182.［19］Colombrit C, Zennaro E, Fallini C, et al. TDP-43 is recruited to stress granules in conditions of oxidative insult［J］. J Neurochem, 2009, 111(4):1051-1061.［20］Wang X, Arai S, Song X, et al. Induced ncRNAs allosterically modify RNA-binding proteins in cis to inhibit transcription［J］. Nature, 454(7200):126-130.［21］Lagier-Tourenne C, Polymenidou M, Cleveland DW, et al. TDP-43 and FUS/TLS: emerging roles in RNA processing and neurodegeneration［J］. Hum Mol Genet, 2010, 19(R1):R46-R64.［22］Vance C, Rogelj B, Hortobagyi T, et al. Mutations in FUS, an RNA processing protein, cause familial amyotrophic lateral sclerosis type 6［J］. Science, 2009, 323(5918):1208-1211.［23］Tan AY, Manley JL. TLS inhibits RNA polymerase Ⅲ transcription［J］. Mol Cell Biol, 2010, 30(1):186-196.［24］Sato S, Idogawa M, Honda K,et al. Beta-catenin interacts with the FUS proto-oncogene product and regulates pre-mRNA splicing［J］. Gastroenterology, 2005, 129(4):1225-1236.［25］Camats M, Guil S, Kokolo M, et al. P68 RNA helicase (DDX5) alters activity of cis- and trans-acting factors of the alternative splicing of H-Ras［J］. PLoS One, 2008, 3（8）:e2926.［26］Lagier-Tourenne C, Cleveland DW. Rethinking ALS: the FUS about TDP-43［J］. Cell, 2009, 136(6):1001-1004.［27］Van Blitterswijk M, Landers JE. RNA processing pathways in amyotrophic lateral sclerosis［J］. Neurogenetics, 2010, 11(3):275-290.［28］Bosco DA, Lemay N, Ko HK, et al. Mutant FUS proteins that cause amyotrophic lateral sclerosis incorporate into stress granules［J］. Hum Mol Genet, 2010, 19(21):4160-4175.［29］Gregory RI, Yan K, Amuthan G, et al. The microprocessor complex mediates the genesis of microRNAs［J］. Nature, 2004, 432(7014):235-240.［30］Arai T, Hasegawa M, Nonoka T, et al. Phosphorylated and cleaved TDP-43 in ALS, FTLD and other neurodegenerative disorders and in cellular models of TDP-43 proteinopathy［J］. Neuropathology, 2010, 30(2):170-181.［31］Mackenzie IR, Bigio EH, Ince PG, et al. Pathological TDP-43 distinguishes sporadic amyotrophic lateral sclerosis from amyotrophic lateral sclerosis with SOD1 mutations［J］. Ann Neurol, 2007, 61(5):427-434.［32］Giordana MT, Piccinini M, Grifoni S, et al. TDP-43 redistribution is an early event in sporadic amyotrophic lateral sclerosis［J］. Brain Pathol, 2010, 20(2):351-360.［33］Neumann M, Kwong LK, Lee EB, et al. Phosphorylation of S409/410 of TDP-43 is a consistent feature in all sporadic and familial forms of TDP-43 proteinopathies［J］. Acta Neuropathol, 2009, 117(2):137-149.［34］King A, Maekawa S, Bodi I, et al. Ubiquitinated, p62 immunopositive cerebellar cortical neuronal inclusions are evident across the spectrum of TDP-43 proteinopathies but are only rarely additionally immunopositive for phosphorylation-dependent TDP-43［J］.Neuropathology, 2010, 31（3）：239-249.［35］Munoz DG, Neumann M, Kusaka H. FUS pathology in basophilic inclusion body disease［J］. Acta Neuropathol, 2009, 118(5):617-627.［36］Suzuki N, Aoki M, Warita H, et al. FALS with FUS mutation in Japan, with early onset, rapid progress and basophilic inclusion［J］. J Hum Genet, 2010, 55(4):252-254.［37］Neumann M, Rademakers R, Roeber S, et al. A new subtype of frontotemporal lobar degeneration with FUS pathsology［J］. Brain, 2009, 132(Pt 11):2922-2931. |
Acta Academiae Medicinae Sinica
